

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.58833002 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.58833002 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.25960032 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.25960032 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.82606294 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.44949495 |
| 7 | triglyceride catabolic process (GO:0019433) | 6.24392159 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 6.15883267 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 6.15883267 |
| 10 | tryptophan catabolic process (GO:0006569) | 6.15883267 |
| 11 | biotin metabolic process (GO:0006768) | 6.13300157 |
| 12 | regulation of sequestering of triglyceride (GO:0010889) | 6.07251534 |
| 13 | kynurenine metabolic process (GO:0070189) | 6.03677657 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.96420488 |
| 15 | low-density lipoprotein particle clearance (GO:0034383) | 5.81629583 |
| 16 | tryptophan metabolic process (GO:0006568) | 5.79390702 |
| 17 | glyoxylate metabolic process (GO:0046487) | 5.77023039 |
| 18 | alpha-linolenic acid metabolic process (GO:0036109) | 5.70636034 |
| 19 | urea cycle (GO:0000050) | 5.68924066 |
| 20 | urea metabolic process (GO:0019627) | 5.68924066 |
| 21 | acylglycerol catabolic process (GO:0046464) | 5.68283607 |
| 22 | neutral lipid catabolic process (GO:0046461) | 5.68283607 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 5.63132591 |
| 24 | negative regulation of fibrinolysis (GO:0051918) | 5.62759620 |
| 25 | regulation of fibrinolysis (GO:0051917) | 5.42003694 |
| 26 | protein carboxylation (GO:0018214) | 5.38019981 |
| 27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.38019981 |
| 28 | sulfur amino acid catabolic process (GO:0000098) | 5.36110984 |
| 29 | cysteine metabolic process (GO:0006534) | 5.32025393 |
| 30 | complement activation, alternative pathway (GO:0006957) | 5.30575713 |
| 31 | regulation of protein activation cascade (GO:2000257) | 5.28943550 |
| 32 | fatty acid transmembrane transport (GO:1902001) | 5.28922647 |
| 33 | nitrogen cycle metabolic process (GO:0071941) | 5.23317502 |
| 34 | serine family amino acid catabolic process (GO:0009071) | 5.13328026 |
| 35 | bile acid metabolic process (GO:0008206) | 5.10119375 |
| 36 | aromatic amino acid family metabolic process (GO:0009072) | 4.95853702 |
| 37 | diacylglycerol metabolic process (GO:0046339) | 4.94262398 |
| 38 | regulation of complement activation (GO:0030449) | 4.93556189 |
| 39 | reverse cholesterol transport (GO:0043691) | 4.92932375 |
| 40 | regulation of triglyceride catabolic process (GO:0010896) | 4.92563452 |
| 41 | regulation of cholesterol esterification (GO:0010872) | 4.92260713 |
| 42 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.91546788 |
| 43 | fatty acid homeostasis (GO:0055089) | 4.89324255 |
| 44 | plasma lipoprotein particle remodeling (GO:0034369) | 4.82869419 |
| 45 | protein-lipid complex remodeling (GO:0034368) | 4.82869419 |
| 46 | macromolecular complex remodeling (GO:0034367) | 4.82869419 |
| 47 | tyrosine metabolic process (GO:0006570) | 4.81376956 |
| 48 | homocysteine metabolic process (GO:0050667) | 4.73248567 |
| 49 | acylglycerol homeostasis (GO:0055090) | 4.69248255 |
| 50 | triglyceride homeostasis (GO:0070328) | 4.69248255 |
| 51 | phospholipid efflux (GO:0033700) | 4.65726487 |
| 52 | alpha-amino acid catabolic process (GO:1901606) | 4.65222702 |
| 53 | negative regulation of sterol transport (GO:0032372) | 4.61961711 |
| 54 | negative regulation of cholesterol transport (GO:0032375) | 4.61961711 |
| 55 | amino-acid betaine metabolic process (GO:0006577) | 4.60291172 |
| 56 | lysine metabolic process (GO:0006553) | 4.55289536 |
| 57 | lysine catabolic process (GO:0006554) | 4.55289536 |
| 58 | cellular ketone body metabolic process (GO:0046950) | 4.48137324 |
| 59 | plasma lipoprotein particle clearance (GO:0034381) | 4.46201470 |
| 60 | imidazole-containing compound metabolic process (GO:0052803) | 4.44194877 |
| 61 | glycine metabolic process (GO:0006544) | 4.41043227 |
| 62 | coenzyme catabolic process (GO:0009109) | 4.40803723 |
| 63 | bile acid and bile salt transport (GO:0015721) | 4.38695391 |
| 64 | carnitine shuttle (GO:0006853) | 4.36219958 |
| 65 | indolalkylamine metabolic process (GO:0006586) | 4.35991372 |
| 66 | negative regulation of complement activation (GO:0045916) | 4.33010439 |
| 67 | cellular amino acid catabolic process (GO:0009063) | 4.27817237 |
| 68 | cellular biogenic amine catabolic process (GO:0042402) | 4.27231356 |
| 69 | amine catabolic process (GO:0009310) | 4.27231356 |
| 70 | cholesterol efflux (GO:0033344) | 4.26864624 |
| 71 | glutamate metabolic process (GO:0006536) | 4.23527517 |
| 72 | cellular glucuronidation (GO:0052695) | 4.20642079 |
| 73 | serine family amino acid metabolic process (GO:0009069) | 4.16667622 |
| 74 | negative regulation of protein activation cascade (GO:2000258) | 4.14246235 |
| 75 | benzene-containing compound metabolic process (GO:0042537) | 4.10000666 |
| 76 | ethanol oxidation (GO:0006069) | 4.09533428 |
| 77 | carnitine transmembrane transport (GO:1902603) | 4.09325415 |
| 78 | glycerolipid catabolic process (GO:0046503) | 4.07394579 |
| 79 | arginine metabolic process (GO:0006525) | 4.04494704 |
| 80 | cellular modified amino acid catabolic process (GO:0042219) | 4.04281483 |
| 81 | plasma lipoprotein particle assembly (GO:0034377) | 4.03901002 |
| 82 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.02646592 |
| 83 | fibrinolysis (GO:0042730) | 4.01400137 |
| 84 | low-density lipoprotein particle remodeling (GO:0034374) | 4.00540623 |
| 85 | serine family amino acid biosynthetic process (GO:0009070) | 3.99972115 |
| 86 | aldehyde catabolic process (GO:0046185) | 3.97487993 |
| 87 | amino-acid betaine transport (GO:0015838) | 3.94050715 |
| 88 | carnitine transport (GO:0015879) | 3.94050715 |
| 89 | ketone body metabolic process (GO:1902224) | 3.87928658 |
| 90 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.87090856 |
| 91 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.87090856 |
| 92 | blood coagulation, intrinsic pathway (GO:0007597) | 3.84648951 |
| 93 | drug catabolic process (GO:0042737) | 3.83668721 |
| 94 | positive regulation of lipid catabolic process (GO:0050996) | 3.79794468 |
| 95 | negative regulation of lipase activity (GO:0060192) | 3.78791833 |
| 96 | cofactor catabolic process (GO:0051187) | 3.78732045 |
| 97 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.76013158 |
| 98 | cholesterol homeostasis (GO:0042632) | 3.76002391 |
| 99 | complement activation, classical pathway (GO:0006958) | 3.75411725 |
| 100 | organic acid catabolic process (GO:0016054) | 3.75251315 |
| 101 | carboxylic acid catabolic process (GO:0046395) | 3.75251315 |
| 102 | phospholipid homeostasis (GO:0055091) | 3.74638202 |
| 103 | uronic acid metabolic process (GO:0006063) | 3.72921698 |
| 104 | glucuronate metabolic process (GO:0019585) | 3.72921698 |
| 105 | complement activation (GO:0006956) | 3.70963898 |
| 106 | regulation of bile acid biosynthetic process (GO:0070857) | 3.70879124 |
| 107 | acetyl-CoA metabolic process (GO:0006084) | 3.70482427 |
| 108 | protein activation cascade (GO:0072376) | 3.69946158 |
| 109 | sterol homeostasis (GO:0055092) | 3.69707799 |
| 110 | cytolysis (GO:0019835) | 3.68372943 |
| 111 | plasma lipoprotein particle organization (GO:0071827) | 3.66700178 |
| 112 | short-chain fatty acid metabolic process (GO:0046459) | 3.66033759 |
| 113 | regulation of cholesterol homeostasis (GO:2000188) | 3.64301884 |
| 114 | protein-lipid complex assembly (GO:0065005) | 3.61885459 |
| 115 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.60499399 |
| 116 | alditol metabolic process (GO:0019400) | 3.60323968 |
| 117 | glycerol metabolic process (GO:0006071) | 3.57809890 |
| 118 | NAD biosynthetic process (GO:0009435) | 3.56202559 |
| 119 | brown fat cell differentiation (GO:0050873) | 3.54917856 |
| 120 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.54258861 |
| 121 | triglyceride biosynthetic process (GO:0019432) | 3.48197716 |
| 122 | neutral lipid biosynthetic process (GO:0046460) | 3.46787312 |
| 123 | acylglycerol biosynthetic process (GO:0046463) | 3.46787312 |
| 124 | pantothenate metabolic process (GO:0015939) | 3.44600809 |
| 125 | white fat cell differentiation (GO:0050872) | 3.41839244 |
| 126 | positive regulation of glycolytic process (GO:0045821) | 3.41079689 |
| 127 | triglyceride metabolic process (GO:0006641) | 3.37935106 |
| 128 | folic acid metabolic process (GO:0046655) | 3.30490876 |
| 129 | iron ion import (GO:0097286) | 3.29821810 |
| 130 | thioester biosynthetic process (GO:0035384) | 3.27455461 |
| 131 | acyl-CoA biosynthetic process (GO:0071616) | 3.27455461 |
| 132 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.26121102 |
| 133 | acylglycerol metabolic process (GO:0006639) | 3.26000650 |
| 134 | neutral lipid metabolic process (GO:0006638) | 3.24987417 |
| 135 | negative regulation of humoral immune response (GO:0002921) | 3.21540938 |
| 136 | coenzyme A biosynthetic process (GO:0015937) | 3.19477787 |
| 137 | oxaloacetate metabolic process (GO:0006107) | 3.17921270 |
| 138 | quaternary ammonium group transport (GO:0015697) | 3.15303457 |
| 139 | response to growth hormone (GO:0060416) | 3.14275357 |
| 140 | thioester metabolic process (GO:0035383) | 3.13923200 |
| 141 | acyl-CoA metabolic process (GO:0006637) | 3.13923200 |
| 142 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.12452724 |
| 143 | L-serine metabolic process (GO:0006563) | 3.10696331 |
| 144 | valine metabolic process (GO:0006573) | 3.04366900 |
| 145 | negative regulation of B cell mediated immunity (GO:0002713) | 2.90338896 |
| 146 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.90338896 |
| 147 | replicative senescence (GO:0090399) | 2.88660481 |
| 148 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.86358313 |
| 149 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.86358313 |
| 150 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.85320953 |
| 151 | primary alcohol metabolic process (GO:0034308) | 2.83873245 |
| 152 | positive regulation of fatty acid oxidation (GO:0046321) | 2.81812587 |
| 153 | coenzyme A metabolic process (GO:0015936) | 2.81570361 |
| 154 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.80138717 |
| 155 | branched-chain amino acid metabolic process (GO:0009081) | 2.79285527 |
| 156 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.75432293 |
| 157 | citrulline biosynthetic process (GO:0019240) | 2.75278238 |
| 158 | fatty acid catabolic process (GO:0009062) | 2.74724384 |
| 159 | regulation of triglyceride metabolic process (GO:0090207) | 2.73960281 |
| 160 | ethanol metabolic process (GO:0006067) | 2.73684137 |
| 161 | fatty acid beta-oxidation (GO:0006635) | 2.72280271 |
| 162 | alkaloid metabolic process (GO:0009820) | 2.71589257 |
| 163 | fatty acid oxidation (GO:0019395) | 2.70689554 |
| 164 | L-methionine biosynthetic process (GO:0071265) | 2.69449866 |
| 165 | amino acid salvage (GO:0043102) | 2.69449866 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.39550910 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.19672081 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.98829936 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.49582176 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.29866822 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.07345344 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.99112990 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.03701521 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.96853470 |
| 10 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.77991220 |
| 11 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.06186409 |
| 12 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.42054128 |
| 13 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.39722597 |
| 14 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.34042975 |
| 15 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.06330040 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.02048707 |
| 17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9499733 |
| 18 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.97404488 |
| 19 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.85450043 |
| 20 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.81508101 |
| 21 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.79224698 |
| 22 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.63404009 |
| 23 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.59973905 |
| 24 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.58098255 |
| 25 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.54050775 |
| 26 | EWS_26573619_Chip-Seq_HEK293_Human | 1.53433723 |
| 27 | GATA1_22025678_ChIP-Seq_K562_Human | 1.44152435 |
| 28 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.40445145 |
| 29 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.40100032 |
| 30 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39587562 |
| 31 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.37453836 |
| 32 | ERA_21632823_ChIP-Seq_H3396_Human | 1.35500011 |
| 33 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.33510514 |
| 34 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.33492842 |
| 35 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.33473408 |
| 36 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.33243924 |
| 37 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.32224186 |
| 38 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.29204280 |
| 39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.28397166 |
| 40 | FUS_26573619_Chip-Seq_HEK293_Human | 1.27825624 |
| 41 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.22724277 |
| 42 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.20228753 |
| 43 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.19366551 |
| 44 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.18853141 |
| 45 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17717363 |
| 46 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.16215872 |
| 47 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.13242268 |
| 48 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.12989640 |
| 49 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12042277 |
| 50 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.10982702 |
| 51 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.09600601 |
| 52 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.08400625 |
| 53 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.07941595 |
| 54 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.07498092 |
| 55 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.07071549 |
| 56 | VDR_22108803_ChIP-Seq_LS180_Human | 1.04817073 |
| 57 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.04482333 |
| 58 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.04480106 |
| 59 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.04480106 |
| 60 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.03719339 |
| 61 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.03157982 |
| 62 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02779224 |
| 63 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.02226059 |
| 64 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.01542216 |
| 65 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.01482653 |
| 66 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.01407770 |
| 67 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.01250346 |
| 68 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99563999 |
| 69 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.95746917 |
| 70 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94241906 |
| 71 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.94076749 |
| 72 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.92935995 |
| 73 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.92285434 |
| 74 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.91652455 |
| 75 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91286997 |
| 76 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.89887777 |
| 77 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.89375075 |
| 78 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.89028072 |
| 79 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.88677778 |
| 80 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.88077896 |
| 81 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.86330851 |
| 82 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.85000694 |
| 83 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.84549078 |
| 84 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.84328776 |
| 85 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.83678959 |
| 86 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83294825 |
| 87 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.81906621 |
| 88 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.81720519 |
| 89 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.79973136 |
| 90 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.79582813 |
| 91 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.79072909 |
| 92 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.77258743 |
| 93 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77230255 |
| 94 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.77027471 |
| 95 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.76644501 |
| 96 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.76276826 |
| 97 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.75976064 |
| 98 | P300_19829295_ChIP-Seq_ESCs_Human | 0.74651805 |
| 99 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.74560181 |
| 100 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.73999585 |
| 101 | STAT3_23295773_ChIP-Seq_U87_Human | 0.73821052 |
| 102 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.73738154 |
| 103 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.73414566 |
| 104 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.73389430 |
| 105 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.72555627 |
| 106 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.72192257 |
| 107 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.71778746 |
| 108 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71602292 |
| 109 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66114319 |
| 110 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.66114114 |
| 111 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.65711535 |
| 112 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.65123420 |
| 113 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.64374614 |
| 114 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.64374614 |
| 115 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.63953536 |
| 116 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.63002582 |
| 117 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62930477 |
| 118 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61018982 |
| 119 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.59906717 |
| 120 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.57816391 |
| 121 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57686415 |
| 122 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.55060710 |
| 123 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.54250505 |
| 124 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.53091769 |
| 125 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52573205 |
| 126 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51678816 |
| 127 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.51350550 |
| 128 | AR_20517297_ChIP-Seq_VCAP_Human | 0.51190172 |
| 129 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.50505956 |
| 130 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.49575446 |
| 131 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48402599 |
| 132 | CBP_21632823_ChIP-Seq_H3396_Human | 0.48086800 |
| 133 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.47484284 |
| 134 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.46932926 |
| 135 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46604777 |
| 136 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.45812577 |
| 137 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.45159013 |
| 138 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.43555605 |
| 139 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.43278851 |
| 140 | GATA1_19941826_ChIP-Seq_K562_Human | 0.43188933 |
| 141 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.42907874 |
| 142 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.42887643 |
| 143 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42840088 |
| 144 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.42486555 |
| 145 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.42195569 |
| 146 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42143597 |
| 147 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.42075269 |
| 148 | GATA2_19941826_ChIP-Seq_K562_Human | 0.40482401 |
| 149 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.40251248 |
| 150 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.40240533 |
| 151 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.40118982 |
| 152 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.38961725 |
| 153 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.38808921 |
| 154 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.38196726 |
| 155 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.37462791 |
| 156 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.37392458 |
| 157 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.36941327 |
| 158 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.35914353 |
| 159 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.35130790 |
| 160 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.34992000 |
| 161 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.34364455 |
| 162 | NCOR_22424771_ChIP-Seq_293T_Human | 0.33670553 |
| 163 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.33484280 |
| 164 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.33196196 |
| 165 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.32913656 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.36350747 |
| 2 | MP0005360_urolithiasis | 7.48869603 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.43708301 |
| 4 | MP0005365_abnormal_bile_salt | 6.19631150 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.05921145 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.23171900 |
| 7 | MP0003252_abnormal_bile_duct | 3.90526009 |
| 8 | MP0004185_abnormal_adipocyte_glucose | 3.86982486 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.63104428 |
| 10 | MP0009840_abnormal_foam_cell | 3.32961743 |
| 11 | MP0005083_abnormal_biliary_tract | 3.06530103 |
| 12 | MP0003195_calcinosis | 2.81569289 |
| 13 | MP0005375_adipose_tissue_phenotype | 2.77378522 |
| 14 | MP0005332_abnormal_amino_acid | 2.75207987 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.58093589 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.36157945 |
| 17 | MP0008057_abnormal_DNA_replication | 2.30031366 |
| 18 | MP0000609_abnormal_liver_physiology | 2.17780457 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 2.13118385 |
| 20 | MP0004019_abnormal_vitamin_homeostasis | 2.11132219 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 1.97319380 |
| 22 | MP0003868_abnormal_feces_composition | 1.92056566 |
| 23 | MP0005319_abnormal_enzyme/_coenzyme | 1.82407156 |
| 24 | MP0001764_abnormal_homeostasis | 1.69356171 |
| 25 | MP0002009_preneoplasia | 1.65786707 |
| 26 | MP0003646_muscle_fatigue | 1.64003739 |
| 27 | MP0009697_abnormal_copulation | 1.59209179 |
| 28 | MP0002132_abnormal_respiratory_system | 1.57436748 |
| 29 | MP0003959_abnormal_lean_body | 1.56892660 |
| 30 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56275747 |
| 31 | MP0005451_abnormal_body_composition | 1.48719004 |
| 32 | MP0000003_abnormal_adipose_tissue | 1.46883856 |
| 33 | MP0005551_abnormal_eye_electrophysiolog | 1.42045366 |
| 34 | MP0002909_abnormal_adrenal_gland | 1.41207095 |
| 35 | MP0003011_delayed_dark_adaptation | 1.39868854 |
| 36 | MP0008058_abnormal_DNA_repair | 1.38872156 |
| 37 | MP0003136_yellow_coat_color | 1.36915959 |
| 38 | MP0005452_abnormal_adipose_tissue | 1.32434578 |
| 39 | MP0002638_abnormal_pupillary_reflex | 1.30027782 |
| 40 | MP0005379_endocrine/exocrine_gland_phen | 1.29017299 |
| 41 | MP0003186_abnormal_redox_activity | 1.26623744 |
| 42 | MP0003656_abnormal_erythrocyte_physiolo | 1.25044145 |
| 43 | MP0006138_congestive_heart_failure | 1.24033595 |
| 44 | MP0009643_abnormal_urine_homeostasis | 1.22202971 |
| 45 | MP0005647_abnormal_sex_gland | 1.18521231 |
| 46 | MP0000598_abnormal_liver_morphology | 1.17220806 |
| 47 | MP0003705_abnormal_hypodermis_morpholog | 1.16949812 |
| 48 | MP0002254_reproductive_system_inflammat | 1.15348670 |
| 49 | MP0010094_abnormal_chromosome_stability | 1.09803447 |
| 50 | MP0000604_amyloidosis | 1.09134200 |
| 51 | MP0009764_decreased_sensitivity_to | 1.04875834 |
| 52 | MP0009763_increased_sensitivity_to | 1.01432111 |
| 53 | MP0003693_abnormal_embryo_hatching | 1.00480895 |
| 54 | MP0002160_abnormal_reproductive_system | 0.99896731 |
| 55 | MP0005174_abnormal_tail_pigmentation | 0.96303278 |
| 56 | MP0010368_abnormal_lymphatic_system | 0.94092496 |
| 57 | MP0003879_abnormal_hair_cell | 0.93836087 |
| 58 | MP0005167_abnormal_blood-brain_barrier | 0.92635432 |
| 59 | MP0000569_abnormal_digit_pigmentation | 0.91058442 |
| 60 | MP0005636_abnormal_mineral_homeostasis | 0.89939053 |
| 61 | MP0002876_abnormal_thyroid_physiology | 0.89886126 |
| 62 | MP0008469_abnormal_protein_level | 0.88325677 |
| 63 | MP0009642_abnormal_blood_homeostasis | 0.86738957 |
| 64 | MP0001986_abnormal_taste_sensitivity | 0.86474503 |
| 65 | MP0002277_abnormal_respiratory_mucosa | 0.84531974 |
| 66 | MP0005670_abnormal_white_adipose | 0.84199046 |
| 67 | MP0006036_abnormal_mitochondrial_physio | 0.82315163 |
| 68 | MP0005408_hypopigmentation | 0.81778641 |
| 69 | MP0005376_homeostasis/metabolism_phenot | 0.80291834 |
| 70 | MP0002078_abnormal_glucose_homeostasis | 0.78959640 |
| 71 | MP0009765_abnormal_xenobiotic_induced | 0.77742190 |
| 72 | MP0005377_hearing/vestibular/ear_phenot | 0.75579485 |
| 73 | MP0003878_abnormal_ear_physiology | 0.75579485 |
| 74 | MP0002971_abnormal_brown_adipose | 0.75519100 |
| 75 | MP0005084_abnormal_gallbladder_morpholo | 0.75423472 |
| 76 | MP0001944_abnormal_pancreas_morphology | 0.74273828 |
| 77 | MP0004130_abnormal_muscle_cell | 0.72950602 |
| 78 | MP0005646_abnormal_pituitary_gland | 0.72280936 |
| 79 | MP0003828_pulmonary_edema | 0.72010171 |
| 80 | MP0005334_abnormal_fat_pad | 0.71990553 |
| 81 | MP0004858_abnormal_nervous_system | 0.71978460 |
| 82 | MP0003690_abnormal_glial_cell | 0.69931918 |
| 83 | MP0005220_abnormal_exocrine_pancreas | 0.69895554 |
| 84 | MP0005253_abnormal_eye_physiology | 0.69751035 |
| 85 | MP0005535_abnormal_body_temperature | 0.69179016 |
| 86 | MP0002166_altered_tumor_susceptibility | 0.69041596 |
| 87 | MP0006292_abnormal_olfactory_placode | 0.66842400 |
| 88 | MP0001661_extended_life_span | 0.65779415 |
| 89 | MP0005266_abnormal_metabolism | 0.65248751 |
| 90 | MP0008775_abnormal_heart_ventricle | 0.65232549 |
| 91 | MP0002736_abnormal_nociception_after | 0.65204687 |
| 92 | MP0001968_abnormal_touch/_nociception | 0.64328159 |
| 93 | MP0009053_abnormal_anal_canal | 0.63590587 |
| 94 | MP0003329_amyloid_beta_deposits | 0.63435695 |
| 95 | MP0003698_abnormal_male_reproductive | 0.62301076 |
| 96 | MP0005410_abnormal_fertilization | 0.62196243 |
| 97 | MP0000639_abnormal_adrenal_gland | 0.60417208 |
| 98 | MP0005076_abnormal_cell_differentiation | 0.59742061 |
| 99 | MP0001756_abnormal_urination | 0.58952518 |
| 100 | MP0005448_abnormal_energy_balance | 0.57980244 |
| 101 | MP0005389_reproductive_system_phenotype | 0.56511558 |
| 102 | MP0006035_abnormal_mitochondrial_morpho | 0.56452111 |
| 103 | MP0001919_abnormal_reproductive_system | 0.55796988 |
| 104 | MP0005187_abnormal_penis_morphology | 0.55714954 |
| 105 | MP0001929_abnormal_gametogenesis | 0.55672130 |
| 106 | MP0001501_abnormal_sleep_pattern | 0.55340561 |
| 107 | MP0005464_abnormal_platelet_physiology | 0.52642594 |
| 108 | MP0002822_catalepsy | 0.49508661 |
| 109 | MP0005395_other_phenotype | 0.48543184 |
| 110 | MP0003638_abnormal_response/metabolism_ | 0.46413022 |
| 111 | MP0008874_decreased_physiological_sensi | 0.45125795 |
| 112 | MP0002928_abnormal_bile_duct | 0.45075231 |
| 113 | MP0003718_maternal_effect | 0.44581301 |
| 114 | MP0002136_abnormal_kidney_physiology | 0.44166021 |
| 115 | MP0002837_dystrophic_cardiac_calcinosis | 0.44084463 |
| 116 | MP0003724_increased_susceptibility_to | 0.43244877 |
| 117 | MP0008873_increased_physiological_sensi | 0.42885328 |
| 118 | MP0004782_abnormal_surfactant_physiolog | 0.42539462 |
| 119 | MP0005666_abnormal_adipose_tissue | 0.42066276 |
| 120 | MP0003436_decreased_susceptibility_to | 0.41326441 |
| 121 | MP0003075_altered_response_to | 0.41258140 |
| 122 | MP0003953_abnormal_hormone_level | 0.41015458 |
| 123 | MP0004381_abnormal_hair_follicle | 0.40596138 |
| 124 | MP0005248_abnormal_Harderian_gland | 0.38524381 |
| 125 | MP0005166_decreased_susceptibility_to | 0.37292832 |
| 126 | MP0008872_abnormal_physiological_respon | 0.36808615 |
| 127 | MP0009672_abnormal_birth_weight | 0.36430925 |
| 128 | MP0009115_abnormal_fat_cell | 0.36137860 |
| 129 | MP0002796_impaired_skin_barrier | 0.35403556 |
| 130 | MP0006082_CNS_inflammation | 0.35095370 |
| 131 | MP0000579_abnormal_nail_morphology | 0.33518233 |
| 132 | MP0002970_abnormal_white_adipose | 0.33198291 |
| 133 | MP0000249_abnormal_blood_vessel | 0.32433920 |
| 134 | MP0004883_abnormal_blood_vessel | 0.32266054 |
| 135 | MP0002168_other_aberrant_phenotype | 0.31830407 |
| 136 | MP0000230_abnormal_systemic_arterial | 0.31518207 |
| 137 | MP0001243_abnormal_dermal_layer | 0.31515397 |
| 138 | MP0001853_heart_inflammation | 0.31409316 |
| 139 | MP0009384_cardiac_valve_regurgitation | 0.30408222 |
| 140 | MP0001881_abnormal_mammary_gland | 0.29344657 |
| 141 | MP0001845_abnormal_inflammatory_respons | 0.27927692 |
| 142 | MP0005164_abnormal_response_to | 0.26008427 |
| 143 | MP0002060_abnormal_skin_morphology | 0.24258739 |
| 144 | MP0002090_abnormal_vision | 0.23817029 |
| 145 | MP0000427_abnormal_hair_cycle | 0.22017140 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.43292874 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.42490776 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.29328247 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.68874679 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.55022795 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.46738378 |
| 7 | Xanthomatosis (HP:0000991) | 6.32752681 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.67146467 |
| 9 | Complement deficiency (HP:0004431) | 5.34896814 |
| 10 | Abnormality of alanine metabolism (HP:0010916) | 4.85593472 |
| 11 | Hyperalaninemia (HP:0003348) | 4.85593472 |
| 12 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 4.85593472 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.84436712 |
| 14 | Joint hemorrhage (HP:0005261) | 4.80266465 |
| 15 | Hyperammonemia (HP:0001987) | 4.62728390 |
| 16 | Epidermoid cyst (HP:0200040) | 4.53618806 |
| 17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.43661164 |
| 18 | Hyperglycinemia (HP:0002154) | 4.43491818 |
| 19 | Abnormality of the common coagulation pathway (HP:0010990) | 4.42967548 |
| 20 | Ketosis (HP:0001946) | 4.28032784 |
| 21 | Abnormality of methionine metabolism (HP:0010901) | 4.27773228 |
| 22 | Hypoalphalipoproteinemia (HP:0003233) | 4.25728347 |
| 23 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.23072009 |
| 24 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.11738253 |
| 25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.11738134 |
| 26 | Fat malabsorption (HP:0002630) | 4.11049992 |
| 27 | Hyperglycinuria (HP:0003108) | 3.94369820 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.93010418 |
| 29 | Abnormality of glycine metabolism (HP:0010895) | 3.93010418 |
| 30 | Abnormality of complement system (HP:0005339) | 3.90186303 |
| 31 | Hypoglycemic coma (HP:0001325) | 3.87337626 |
| 32 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.83020137 |
| 33 | Abnormality of the intrinsic pathway (HP:0010989) | 3.75744511 |
| 34 | Conjugated hyperbilirubinemia (HP:0002908) | 3.67365619 |
| 35 | Hypercholesterolemia (HP:0003124) | 3.63212742 |
| 36 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.41503253 |
| 37 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.37330640 |
| 38 | Hyperbilirubinemia (HP:0002904) | 3.32622417 |
| 39 | Steatorrhea (HP:0002570) | 3.10458959 |
| 40 | Delayed CNS myelination (HP:0002188) | 3.09474281 |
| 41 | Abnormality of serum amino acid levels (HP:0003112) | 3.07504832 |
| 42 | Abnormality of nucleobase metabolism (HP:0010932) | 3.04671338 |
| 43 | Ketoacidosis (HP:0001993) | 3.01050825 |
| 44 | Hypochromic microcytic anemia (HP:0004840) | 3.00364238 |
| 45 | Spontaneous abortion (HP:0005268) | 2.99953616 |
| 46 | Hepatocellular carcinoma (HP:0001402) | 2.98190577 |
| 47 | Myocardial infarction (HP:0001658) | 2.95736744 |
| 48 | Skin nodule (HP:0200036) | 2.79742570 |
| 49 | Metabolic acidosis (HP:0001942) | 2.76443487 |
| 50 | Hypertriglyceridemia (HP:0002155) | 2.73568047 |
| 51 | Systemic lupus erythematosus (HP:0002725) | 2.72845300 |
| 52 | Abnormality of purine metabolism (HP:0004352) | 2.65496938 |
| 53 | Testicular atrophy (HP:0000029) | 2.63601708 |
| 54 | Impulsivity (HP:0100710) | 2.60693847 |
| 55 | Lethargy (HP:0001254) | 2.59785796 |
| 56 | Dicarboxylic aciduria (HP:0003215) | 2.59764055 |
| 57 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.59764055 |
| 58 | Congenital stationary night blindness (HP:0007642) | 2.59476354 |
| 59 | Vascular calcification (HP:0004934) | 2.54941037 |
| 60 | Acanthocytosis (HP:0001927) | 2.54244465 |
| 61 | Reduced antithrombin III activity (HP:0001976) | 2.53083303 |
| 62 | Abnormal gallbladder morphology (HP:0012437) | 2.50861493 |
| 63 | Spastic diplegia (HP:0001264) | 2.46947743 |
| 64 | Hypoglycemic seizures (HP:0002173) | 2.46782987 |
| 65 | Cholelithiasis (HP:0001081) | 2.45271616 |
| 66 | Megaloblastic anemia (HP:0001889) | 2.42623409 |
| 67 | Cerebral edema (HP:0002181) | 2.41636056 |
| 68 | Gout (HP:0001997) | 2.41169116 |
| 69 | Mitral stenosis (HP:0001718) | 2.41033705 |
| 70 | Glomerulonephritis (HP:0000099) | 2.38917196 |
| 71 | Increased muscle lipid content (HP:0009058) | 2.38084610 |
| 72 | Cholecystitis (HP:0001082) | 2.36851588 |
| 73 | Abnormal gallbladder physiology (HP:0012438) | 2.36851588 |
| 74 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.35756265 |
| 75 | Oligomenorrhea (HP:0000876) | 2.35430578 |
| 76 | Pigmentary retinal degeneration (HP:0001146) | 2.35275359 |
| 77 | Neonatal onset (HP:0003623) | 2.35177830 |
| 78 | Irritability (HP:0000737) | 2.34578425 |
| 79 | Amyloidosis (HP:0011034) | 2.33030945 |
| 80 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.32398830 |
| 81 | Malnutrition (HP:0004395) | 2.27286658 |
| 82 | Cardiovascular calcification (HP:0011915) | 2.26438001 |
| 83 | Birth length less than 3rd percentile (HP:0003561) | 2.23711708 |
| 84 | Bile duct proliferation (HP:0001408) | 2.20872969 |
| 85 | Abnormal biliary tract physiology (HP:0012439) | 2.20872969 |
| 86 | Gingival bleeding (HP:0000225) | 2.20786758 |
| 87 | Esophageal varix (HP:0002040) | 2.17637515 |
| 88 | Pancreatitis (HP:0001733) | 2.16454827 |
| 89 | Brushfield spots (HP:0001088) | 2.16029377 |
| 90 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.15909059 |
| 91 | Menorrhagia (HP:0000132) | 2.14602004 |
| 92 | Sensorimotor neuropathy (HP:0007141) | 2.14396439 |
| 93 | Cerebellar dysplasia (HP:0007033) | 2.12293632 |
| 94 | Enlarged kidneys (HP:0000105) | 2.11880928 |
| 95 | Type I transferrin isoform profile (HP:0003642) | 2.10937976 |
| 96 | Late onset (HP:0003584) | 2.10459432 |
| 97 | Abnormality of homocysteine metabolism (HP:0010919) | 2.08431709 |
| 98 | Homocystinuria (HP:0002156) | 2.08431709 |
| 99 | Hyperventilation (HP:0002883) | 2.08047231 |
| 100 | Thrombophlebitis (HP:0004418) | 2.07469815 |
| 101 | Vomiting (HP:0002013) | 2.06744460 |
| 102 | Hypochromic anemia (HP:0001931) | 2.05753117 |
| 103 | Attenuation of retinal blood vessels (HP:0007843) | 2.03939174 |
| 104 | Abnormality of the gallbladder (HP:0005264) | 2.03595883 |
| 105 | Neonatal hypoglycemia (HP:0001998) | 2.03298667 |
| 106 | Increased serum pyruvate (HP:0003542) | 2.03001852 |
| 107 | Poikilocytosis (HP:0004447) | 2.02957011 |
| 108 | Opisthotonus (HP:0002179) | 2.02881153 |
| 109 | Increased serum lactate (HP:0002151) | 2.02754437 |
| 110 | Hemorrhage of the eye (HP:0011885) | 2.02663641 |
| 111 | Generalized aminoaciduria (HP:0002909) | 2.01796848 |
| 112 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.00318612 |
| 113 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.98940823 |
| 114 | Acute hepatic failure (HP:0006554) | 1.98448988 |
| 115 | Long foot (HP:0001833) | 1.97070367 |
| 116 | Fair hair (HP:0002286) | 1.96037707 |
| 117 | Rickets (HP:0002748) | 1.93864117 |
| 118 | Hepatic necrosis (HP:0002605) | 1.93101342 |
| 119 | Abnormality of iron homeostasis (HP:0011031) | 1.90905973 |
| 120 | Duplicated collecting system (HP:0000081) | 1.90556327 |
| 121 | Increased CSF lactate (HP:0002490) | 1.89371569 |
| 122 | Abnormal cartilage morphology (HP:0002763) | 1.88793462 |
| 123 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.87862974 |
| 124 | Abnormality of the pons (HP:0007361) | 1.87797136 |
| 125 | Hydroxyprolinuria (HP:0003080) | 1.87726352 |
| 126 | Abnormality of proline metabolism (HP:0010907) | 1.87726352 |
| 127 | Renal cortical cysts (HP:0000803) | 1.87126099 |
| 128 | Toxemia of pregnancy (HP:0100603) | 1.85257437 |
| 129 | Hypophosphatemic rickets (HP:0004912) | 1.84687883 |
| 130 | Retinal atrophy (HP:0001105) | 1.83891438 |
| 131 | Elevated hepatic transaminases (HP:0002910) | 1.82084337 |
| 132 | Methylmalonic aciduria (HP:0012120) | 1.81537866 |
| 133 | Abnormality of glycolysis (HP:0004366) | 1.80806131 |
| 134 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.78902657 |
| 135 | Status epilepticus (HP:0002133) | 1.78695382 |
| 136 | Lactic acidosis (HP:0003128) | 1.78228341 |
| 137 | Alkalosis (HP:0001948) | 1.77873469 |
| 138 | CNS demyelination (HP:0007305) | 1.77208523 |
| 139 | Pancreatic cysts (HP:0001737) | 1.76565973 |
| 140 | Clitoromegaly (HP:0000057) | 1.76505166 |
| 141 | Amelogenesis imperfecta (HP:0000705) | 1.76149726 |
| 142 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.76067232 |
| 143 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.76067232 |
| 144 | Abnormal protein glycosylation (HP:0012346) | 1.76067232 |
| 145 | Abnormal glycosylation (HP:0012345) | 1.76067232 |
| 146 | Acute encephalopathy (HP:0006846) | 1.75977503 |
| 147 | Abnormality of the renal cortex (HP:0011035) | 1.75213515 |
| 148 | Gaze-evoked nystagmus (HP:0000640) | 1.75209722 |
| 149 | Nausea (HP:0002018) | 1.75184633 |
| 150 | Hyperglycemia (HP:0003074) | 1.73295078 |
| 151 | Abnormality of vitamin metabolism (HP:0100508) | 1.73135735 |
| 152 | Reticulocytosis (HP:0001923) | 1.71574076 |
| 153 | Hypoplasia of the pons (HP:0012110) | 1.71448323 |
| 154 | Vaginal fistula (HP:0004320) | 1.71304386 |
| 155 | Limb hypertonia (HP:0002509) | 1.71091277 |
| 156 | Methylmalonic acidemia (HP:0002912) | 1.70614920 |
| 157 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.65715960 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.24900736 |
| 2 | FGFR4 | 4.63563515 |
| 3 | SIK1 | 4.63409836 |
| 4 | ERN1 | 4.41090720 |
| 5 | PDK2 | 4.38842071 |
| 6 | ZAK | 3.35306681 |
| 7 | TAOK3 | 2.99496784 |
| 8 | INSRR | 2.94463333 |
| 9 | ERBB4 | 2.83502378 |
| 10 | BMPR1B | 2.75589594 |
| 11 | AKT3 | 2.48622992 |
| 12 | TNK2 | 2.37899802 |
| 13 | MAP2K4 | 2.33561291 |
| 14 | RIPK4 | 2.29021702 |
| 15 | ACVR1B | 2.27470762 |
| 16 | PKN2 | 2.26422081 |
| 17 | WNK4 | 2.23622638 |
| 18 | MST1R | 2.07748703 |
| 19 | FLT3 | 1.92806430 |
| 20 | TRIB3 | 1.86511830 |
| 21 | PIK3CG | 1.86509398 |
| 22 | MAPK11 | 1.85258943 |
| 23 | CAMKK2 | 1.83401470 |
| 24 | CDC7 | 1.80213581 |
| 25 | EEF2K | 1.74026132 |
| 26 | TYK2 | 1.70282992 |
| 27 | STK39 | 1.67683927 |
| 28 | LATS1 | 1.59724248 |
| 29 | BRSK2 | 1.55424882 |
| 30 | MAP4K2 | 1.53579326 |
| 31 | DAPK2 | 1.53554491 |
| 32 | ABL2 | 1.47128774 |
| 33 | PTK6 | 1.46214174 |
| 34 | CAMK1 | 1.42316385 |
| 35 | OXSR1 | 1.41468735 |
| 36 | FGFR2 | 1.40063423 |
| 37 | NEK9 | 1.39268291 |
| 38 | YES1 | 1.38024662 |
| 39 | STK16 | 1.35454187 |
| 40 | BLK | 1.33858926 |
| 41 | FRK | 1.32437505 |
| 42 | KDR | 1.30987760 |
| 43 | TLK1 | 1.23560554 |
| 44 | JAK2 | 1.23034655 |
| 45 | MAP3K7 | 1.19880537 |
| 46 | PINK1 | 1.17942628 |
| 47 | PRKAA2 | 1.16550883 |
| 48 | WNK3 | 1.08984033 |
| 49 | MAP2K3 | 1.07752335 |
| 50 | TBK1 | 1.07242485 |
| 51 | NUAK1 | 1.06740059 |
| 52 | GRK6 | 1.06721966 |
| 53 | MAP3K14 | 1.06632648 |
| 54 | MAP3K10 | 1.03284820 |
| 55 | JAK1 | 1.02315239 |
| 56 | STK11 | 0.99526036 |
| 57 | ERBB2 | 0.98874899 |
| 58 | MAPK4 | 0.97430375 |
| 59 | MAPK15 | 0.95940628 |
| 60 | PRKD3 | 0.93223609 |
| 61 | PRKCZ | 0.91911275 |
| 62 | FES | 0.91407931 |
| 63 | ATR | 0.87891715 |
| 64 | IRAK4 | 0.87777254 |
| 65 | EPHB1 | 0.87473591 |
| 66 | ADRBK2 | 0.84303707 |
| 67 | CDK6 | 0.84299931 |
| 68 | MAP3K3 | 0.83249330 |
| 69 | MET | 0.82379211 |
| 70 | TIE1 | 0.81267229 |
| 71 | STK38L | 0.81147263 |
| 72 | MAPK12 | 0.80748810 |
| 73 | CAMK1D | 0.79518051 |
| 74 | EPHA3 | 0.79169482 |
| 75 | FER | 0.78566249 |
| 76 | DYRK3 | 0.78235985 |
| 77 | NME1 | 0.77824275 |
| 78 | MAP3K11 | 0.76644786 |
| 79 | PRKACG | 0.76410236 |
| 80 | CDK3 | 0.73986965 |
| 81 | MAPK13 | 0.73670501 |
| 82 | MKNK1 | 0.72991366 |
| 83 | DYRK1B | 0.72788960 |
| 84 | TEC | 0.71636622 |
| 85 | CSK | 0.70437381 |
| 86 | CAMK2G | 0.70102173 |
| 87 | GSK3A | 0.68276198 |
| 88 | MAP2K6 | 0.67456750 |
| 89 | IRAK3 | 0.67420751 |
| 90 | ADRBK1 | 0.67190737 |
| 91 | RAF1 | 0.67108052 |
| 92 | TTK | 0.66659070 |
| 93 | PRKAA1 | 0.64824338 |
| 94 | RPS6KA5 | 0.63524593 |
| 95 | PIM1 | 0.61379046 |
| 96 | FGFR3 | 0.61002116 |
| 97 | CHEK2 | 0.59680218 |
| 98 | SGK3 | 0.59417164 |
| 99 | TGFBR2 | 0.59255966 |
| 100 | RIPK1 | 0.58784342 |
| 101 | MAPK7 | 0.56948116 |
| 102 | IKBKE | 0.55873242 |
| 103 | PTK2 | 0.55527488 |
| 104 | SRPK1 | 0.55109589 |
| 105 | CSF1R | 0.54451010 |
| 106 | RPS6KB2 | 0.53990139 |
| 107 | PDPK1 | 0.52784721 |
| 108 | PRKCQ | 0.52568234 |
| 109 | MAPKAPK5 | 0.49794775 |
| 110 | CSNK1G1 | 0.49790148 |
| 111 | GRK5 | 0.48286879 |
| 112 | MAPKAPK3 | 0.48218454 |
| 113 | GRK1 | 0.48112436 |
| 114 | WNK1 | 0.46256030 |
| 115 | AKT1 | 0.46105208 |
| 116 | EPHA4 | 0.46003330 |
| 117 | EIF2AK1 | 0.45930639 |
| 118 | PRKACB | 0.45610367 |
| 119 | TAOK2 | 0.44246197 |
| 120 | IGF1R | 0.44066995 |
| 121 | MAP2K1 | 0.43259193 |
| 122 | RET | 0.43250673 |
| 123 | PLK3 | 0.43058298 |
| 124 | CDK4 | 0.42390516 |
| 125 | SGK2 | 0.41968846 |
| 126 | MAP3K5 | 0.41884406 |
| 127 | MAP3K13 | 0.40780765 |
| 128 | ICK | 0.40253732 |
| 129 | CDK7 | 0.39939298 |
| 130 | PRKCG | 0.39534085 |
| 131 | ATM | 0.39498217 |
| 132 | PKN1 | 0.38867514 |
| 133 | TSSK6 | 0.38461775 |
| 134 | MAP3K6 | 0.37365338 |
| 135 | AKT2 | 0.36744549 |
| 136 | MTOR | 0.35767915 |
| 137 | STK3 | 0.34230340 |
| 138 | TAOK1 | 0.33868932 |
| 139 | EGFR | 0.33358360 |
| 140 | RPS6KA4 | 0.33303224 |
| 141 | PDK1 | 0.32786016 |
| 142 | CAMK4 | 0.31743353 |
| 143 | PBK | 0.31459094 |
| 144 | PLK1 | 0.30542082 |
| 145 | CAMK1G | 0.30525309 |
| 146 | EIF2AK2 | 0.30224608 |
| 147 | MAP3K1 | 0.29655745 |
| 148 | MKNK2 | 0.29322618 |
| 149 | SGK223 | 0.29121613 |
| 150 | SGK494 | 0.29121613 |
| 151 | HCK | 0.29046414 |
| 152 | LYN | 0.29029030 |
| 153 | CSNK1G2 | 0.28607523 |
| 154 | LATS2 | 0.26799284 |
| 155 | IRAK1 | 0.26757399 |
| 156 | CSNK1G3 | 0.26699592 |
| 157 | PRKCA | 0.25239770 |
| 158 | IRAK2 | 0.24868248 |
| 159 | MAP2K2 | 0.21777595 |
| 160 | ABL1 | 0.21095485 |
| 161 | PDK4 | 0.20243575 |
| 162 | PDK3 | 0.20243575 |
| 163 | PAK3 | 0.19183277 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.53960238 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.54387562 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.39040218 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.33663005 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.07873241 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.75192171 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.74451146 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.68967617 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.63493628 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.54255273 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.51296306 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.40295172 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.23814948 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.16145158 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.12054989 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.09617233 |
| 17 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.99195478 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.94899660 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.93667219 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.92336344 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.91312488 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.90985950 |
| 23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.90791453 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.84285799 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.75502014 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.74337092 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.74125405 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.72292782 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.69805245 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.67881355 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65284030 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.61751203 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.57029829 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.56615842 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.51662498 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50404419 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.47952664 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.45480736 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.38203539 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.37269343 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.33912479 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.31582696 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26478607 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.20757934 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.19727952 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19584557 |
| 47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.19039243 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.18770749 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12691920 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.04808286 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.99669589 |
| 52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.99333491 |
| 53 | Homologous recombination_Homo sapiens_hsa03440 | 0.98511021 |
| 54 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.97373439 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.97038508 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95874639 |
| 57 | Sulfur relay system_Homo sapiens_hsa04122 | 0.94611306 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86823510 |
| 59 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.85428890 |
| 60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.83339894 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 0.80876772 |
| 62 | RNA polymerase_Homo sapiens_hsa03020 | 0.77693163 |
| 63 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.77563849 |
| 64 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.74895757 |
| 65 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.71125392 |
| 66 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69697838 |
| 67 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69333946 |
| 68 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.66894721 |
| 69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63870765 |
| 70 | DNA replication_Homo sapiens_hsa03030 | 0.61835568 |
| 71 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.57608617 |
| 72 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56641970 |
| 73 | Purine metabolism_Homo sapiens_hsa00230 | 0.56437064 |
| 74 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.55929022 |
| 75 | Mismatch repair_Homo sapiens_hsa03430 | 0.52798889 |
| 76 | Base excision repair_Homo sapiens_hsa03410 | 0.48437014 |
| 77 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.47400718 |
| 78 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.46525006 |
| 79 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45842898 |
| 80 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.41908100 |
| 81 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.39966719 |
| 82 | Prion diseases_Homo sapiens_hsa05020 | 0.36961768 |
| 83 | Basal transcription factors_Homo sapiens_hsa03022 | 0.28994283 |
| 84 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27700576 |
| 85 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.26361151 |
| 86 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25198806 |
| 87 | Insulin resistance_Homo sapiens_hsa04931 | 0.23651488 |
| 88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23395007 |
| 89 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22669524 |
| 90 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22587838 |
| 91 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19016880 |
| 92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17317816 |
| 93 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10316876 |
| 94 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03042255 |
| 95 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2361576 |
| 96 | Amoebiasis_Homo sapiens_hsa05146 | -0.2349147 |
| 97 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2348457 |
| 98 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2320068 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2293072 |
| 100 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.2027567 |
| 101 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1988060 |
| 102 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1952462 |
| 103 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1951942 |
| 104 | Hepatitis C_Homo sapiens_hsa05160 | -0.1820674 |
| 105 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1569857 |
| 106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1548660 |
| 107 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1536871 |
| 108 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1488970 |
| 109 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1400097 |
| 110 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1308253 |
| 111 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0946041 |
| 112 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0837020 |
| 113 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0795281 |
| 114 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0716329 |
| 115 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0344033 |

